CTRI/2021/02/031493已完成未知
A single centre, prospective, multiple arms, randomised, open label, 7-day study to assess under dermatological control, the in-use skin compatibility and cosmetic acceptability of a range of four Dettol bar soaps for use on the face
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 132
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1) Subject able to give written informed consent and from whom written informed consent has been obtained.
- •2) Healthy male and female subjects between the ages of 18 and 55 years inclusive at the time of informal consent.
- •3) Subject with Fitzpatrick Scale Phototype III to V skin
- •4) Subjects who are able to understand the study, co-operate with the study procedures and prohibitions, and are able to attend all study assessments.
排除标准
- •1) Female subject who is pregnant (self-report), lactating, have given birth within the previous 3 months or are planning to become pregnant in the duration of the study.
- •2) Female subjects of childbearing potential who, for the duration of the study, are either unwilling or unable to take adequate contraceptive precautions or are unwilling to be sexually abstinent.
- •3) Subject with known skin disorders (acne, psoriasis, eczema, rosacea, or other).
- •4) Subjects with dry or sensitive skin on the face (interrogation of skin type by questionnaire and dermatologist assessment).
- •5) Subject with dryness or irritation on the face or hands at the screening.
- •6) Subject with known allergies to any of the test product ingredients.
- •7) Subject with excessive hair growth on the face that in opinion if the Investigator will hinder visual assessment of the test site. Subjects with freckles, beauty spots, birthmarks, or a tattoo at the test site.
- •8) Subject with a history of type 1 or type 2 diabetes.
- •9) Subject with peripheral vascular disease or poor blood circulation (self-reported).
- •10) Subject with a significant past medical history of the hepatic, renal, cardiac, pulmonary, digestive, haematological, endocrinological, neurological, locomotor, or psychiatric disease which, in the opinion of the investigator, would compromise the safety of the subject.
- •11) Subject with a history of skin tumours or malignant disease.
- •12) Subject whose skin has been excessively exposed to the sun or to UV rays during the previous month in the opinion of the Investigator.
- •13) Subject who is suffering from chronic asthma, a malfunction of the lymphatic system, or an autoimmune deficiency disease (e.g. lupus, thyroiditis).
- •14) Subject taking antihistamine or steroid preparations, any medication for the treatment of diabetes mellitus, immunosuppressive drugs, or any other medication which, in the opinion of the investigator, may affect the test results.
- •15) Subject who has a history of excessive drug or alcohol use (in line with national guidance) which will affect the test results in the opinion of the Investigator.
- •16) Subject with any conditions, which in the opinion of the investigator, may affect the results of the study.
- •17) Subject who has participated in any clinical study during the previous month or are currently participating in a separate clinical study.
- •18) Employee at the study site.
- •19) Any partner or first-degree relative of the subject who has a role in the study at the vendor site.
- •20) Subject unable in the opinion of the Investigator to comply fully with the study requirements.
研究者
相似试验
进行中（未招募）
1 期
A Multiple Arm, Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Phase 2 Study of Intra-Articular Administration of an Allogeneic Human Placental Tissue Particulate (PTP-001) for the Treatment of Knee OsteoarthritisEUCTR2021-003395-13-DKBioventus LLC210
已完成
不适用
Multi-center, Prospective, Single Arm, Pivotal study to evaluate the efficacy and safety of ‘easyUretero 100’, robotic-assisted surgery system in patients in need of Retrograde Intrarenal SurgeryKCT0007506EasyEndo Surgical47
尚未招募
Unknown
Study to evaluate safety and efficacy of TAVI -Transcatheter Aortic Valve (Crea Aortic Valve)CTRI/2024/01/061426Onecrea Medical India
尚未招募
不适用
Vitamin D Supplementation in Rheumatoid ArthritisCTRI/2021/04/032530Dr Arindam Nandy Roy
尚未招募
2 期
Efeectiveness of chukku legiyam in the treatment of moolam (Haemorroids)CTRI/2023/09/057686ational Institute Of Siddha